Also, no evidence of pancreatic injury or pancreatitis was detected on short term treatment of low-dose sitagliptin in the current rat model of type 2 DM, as confirmed by the H&E staining, immunohistochemical observations of iNOS immunostaining, and the biochemical findings of serum lipase. The gene discussed is NOS2; the disease is pancreatitis.